Vitreoretinopathy – A Complete Patient‑Friendly Guide
Overview
Vitreoretinopathy refers to a group of disorders in which the vitreous body (the clear gel that fills the eye) pulls on, adheres to, or damages the retina. The most common form is **posterior vitreous detachment (PVD)**‑related vitreoretinopathy, but the term also encompasses proliferative vitreoretinopathy (PVR) that can follow retinal detachment or trauma.
- Who it affects: Adults over 50 are most frequently affected by PVD‑related vitreoretinopathy, while PVR can occur at any age after retinal injury or surgery.
- Prevalence: Approximately 15–20% of people over 70 develop a PVD each year, and up to 5% of those develop vitreoretinopathy complications that require treatment [1]. Proliferative vitreoretinopathy accounts for about 5–10% of all retinal detachment cases [2].
Symptoms
Symptoms vary depending on the underlying mechanism (traction, membrane formation, or retinal tears). Watch for any new visual changes and report them promptly.
Common symptoms
- Floaters: Small, dark, moving specks that drift across the visual field.
- Flashes of light (photopsia): Brief, bright streaks often described as “copper wiring” or “sparkles.”
- Decreased visual acuity: Blurry or hazy vision that does not improve with glasses.
- Distorted vision (metamorphopsia): Straight lines appear wavy or bent.
- Dark curtain or shadow: A partial loss of peripheral vision, often indicating a retinal tear or detachment.
- Eye pain or discomfort: Usually mild, but can be present if inflammation accompanies the vitreoretinopathy.
Less common but concerning symptoms
- Sudden loss of central vision.
- Persistent headache with visual changes.
- Double vision (diplopia) when the retinal surface is severely distorted.
Causes and Risk Factors
Vitreoretinopathy is usually a result of abnormal traction between the vitreous and the retina. The underlying reasons differ between its subtypes.
Posterior Vitreous Detachment‑related vitreoretinopathy
- Aging: The vitreous gel liquefies (synchysis) and shrinks, pulling away from the retina.
- High myopia (nearsightedness): Elongated eyeball stretches the retina, increasing traction.
- Trauma: Blunt eye injury can accelerate vitreous separation.
- Previous eye surgery: Cataract extraction or laser procedures can alter vitreoretinal adhesion.
Proliferative Vitreoretinopathy (PVR)
- Retinal detachment: When the retina lifts, retinal cells can proliferate and form contractile membranes.
- Severe ocular inflammation: Uveitis or infections stimulate scar tissue.
- Ocular trauma or penetrating injuries.
- Genetic predisposition: Certain HLA types have been linked to aggressive PVR (study [3]).
General risk factors
- Age ≥50 years (especially >70).
- Myopia of –6.00 D or greater.
- Family history of retinal disease.
- Systemic diseases: Diabetes mellitus, hypertension, and connective‑tissue disorders (e.g., Marfan syndrome).
Diagnosis
Early detection relies on a thorough eye examination performed by an ophthalmologist or retinal specialist.
Clinical examination
- Visual acuity testing: Determines baseline vision.
- Dilated fundus exam: Uses ophthalmoscopy to view the retina and vitreous after pupil dilation.
- Slit‑lamp biomicroscopy with a special lens: Allows detailed assessment of peripheral retinal tears.
Imaging and ancillary tests
- Optical Coherence Tomography (OCT): Cross‑sectional imaging that reveals vitreoretinal traction, macular edema, or epiretinal membranes.
- B‑scan ultrasonography: Useful when media opacity (cataract, vitreous hemorrhage) blocks direct view.
- Fundus photography: Documents baseline retinal status for comparison.
- Fluorescein angiography (FA): Rarely required, but can show leakage from neovascular membranes.
Treatment Options
Management is tailored to severity, symptom burden, and risk of retinal detachment.
Observation
In uncomplicated PVD without retinal tears, regular monitoring every 6–12 months is often sufficient.
Laser photocoagulation
- Applied to retinal tears or areas of traction to create adhesion points, preventing progression to detachment.
- Typically performed in an outpatient setting; sessions last <10 minutes.
Scleral buckle surgery
- Indicated for localized retinal detachments where traction is the main issue.
- A silicone band is sutured around the eye to “buckle” the sclera and re‑approximate the retina.
Pars plana vitrectomy (PPV)
- The gold standard for advanced vitreoretinopathy, especially proliferative or tractional retinal detachments.
- The surgeon removes the vitreous gel, releases traction, and may place a gas or silicone oil tamponade to keep the retina flat.
- Recovery time: 4–6 weeks for visual stabilization.
Pharmacologic adjuncts
- Corticosteroid intravitreal injections: Reduce inflammation in PVR or uveitic vitreoretinopathy.
- Anti‑VEGF agents (e.g., ranibizumab, aflibercept): Helpful when neovascular membranes accompany traction.
Lifestyle & supportive measures
- Protect eyes from trauma (safety glasses).
- Control systemic diseases—especially blood pressure and blood sugar.
- Limit activities that cause sudden eye movement (e.g., heavy weight‑lifting) during acute phases.
Living with Vitreoretinopathy
While some patients recover excellent vision after treatment, many need ongoing self‑care.
Daily management tips
- Regular eye exams: At least once a year, or sooner if you notice new symptoms.
- Protective eyewear: UV‑blocking sunglasses reduce oxidative stress on the retina.
- Monitor visual changes: Keep a simple diary of floaters, flashes, or vision loss.
- Healthy diet: Foods rich in omega‑3 fatty acids (salmon, flaxseed) and antioxidants (leafy greens) support retinal health.
- Smoking cessation: Smoking doubles the risk of retinal degeneration.
- Adhere to medication schedules: Intravitreal injections or oral steroids must be given exactly as prescribed.
Rehabilitation
- Low Vision Aids: Magnifiers, high‑contrast reading glasses, or electronic devices can improve functional vision.
- Occupational therapy: Training to adapt daily activities when central vision is compromised.
Prevention
While aging cannot be stopped, several measures can lower the likelihood of vitreoretinopathy or its complications.
- Maintain a healthy weight and control diabetes, hypertension, and hyperlipidemia.
- Undergo regular dilated eye exams after age 40, especially if you are highly myopic.
- Wear protective eyewear during sports, construction work, or any activity with a risk of ocular trauma.
- Limit caffeine and alcohol excess, which can exacerbate vitreous liquefaction.
- Stay hydrated—adequate systemic hydration may help maintain vitreous consistency.
Complications
If left untreated, vitreoretinopathy can lead to serious, vision‑threatening problems.
- Rhegmatogenous retinal detachment: A tear allows fluid to accumulate under the retina, causing separation.
- Proliferative vitreoretinopathy (PVR): Scar tissue contracts, pulling the retina off its underlying layers.
- Macular edema: Fluid buildup in the central retina, leading to central vision loss.
- Epiretinal membrane (ERM): A semi‑transparent sheet on the retinal surface that causes distortion.
- Permanent vision loss: Especially if the macula or optic nerve becomes compromised.
When to Seek Emergency Care
Call 911 or go to the nearest emergency department immediately if you experience any of the following:
- Sudden appearance of a dark curtain or shadow covering part of your visual field.
- Rapid loss of central vision or a dramatic drop in visual acuity.
- New, persistent flashes of light accompanied by a sudden increase in floaters.
- Severe eye pain with nausea or vomiting.
These signs may indicate an acute retinal detachment or a rapidly progressing vitreoretinal traction that requires prompt surgical intervention.
References:
- Mayo Clinic. “Posterior vitreous detachment.” Updated 2023. https://www.mayoclinic.org
- Cleveland Clinic. “Proliferative vitreoretinopathy.” 2022. https://my.clevelandclinic.org
- American Journal of Ophthalmology. “Genetic markers for aggressive PVR.” 2021;228:45‑53.
- National Eye Institute (NEI). “Age‑related eye disease statistics.” 2022. https://nei.nih.gov
- World Health Organization. “Global prevalence of myopia.” 2020. https://www.who.int